The role of microRNAs in ovarian cancer

Y Kinose, K Sawada, K Nakamura… - BioMed research …, 2014 - Wiley Online Library
Ovarian cancer is the most lethal of malignant gynecological tumors. Its lethality may be due
to difficulties in detecting it at an early stage and lack of effective treatments for patients with …

[HTML][HTML] MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer

MK Pal, SP Jaiswar, VN Dwivedi… - Cancer biology & …, 2015 - ncbi.nlm.nih.gov
Epithelial ovarian cancer (EOC) is the leading cause of death among all gynecological
malignancies. Despite the technological and medical advances over the past four decades …

Role of microRNAs as clinical cancer biomarkers for ovarian cancer: a short overview

CE Staicu, DV Predescu, CM Rusu, BM Radu… - Cells, 2020 - mdpi.com
Ovarian cancer has the highest mortality rate among gynecological cancers. Early clinical
signs are missing and there is an urgent need to establish early diagnosis biomarkers …

MicroRNA in ovarian cancer: biology, pathogenesis, and therapeutic opportunities

SN Chen, R Chang, LT Lin, CU Chern, HW Tsai… - International journal of …, 2019 - mdpi.com
Ovarian cancer comprises one of the three major malignant tumor types in the female
reproductive system. The mortality rate of this cancer is the highest among all gynecological …

Current status and implications of microRNAs in ovarian cancer diagnosis and therapy

MS Zaman, DM Maher, S Khan, M Jaggi… - Journal of ovarian …, 2012 - Springer
Ovarian cancer is the fifth most common cancer among women and causes more deaths
than any other type of female reproductive cancer. Currently, treatment of ovarian cancer is …

[HTML][HTML] Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer

H Zheng, JY Liu, FJ Song, KX Chen - Cancer biology & medicine, 2013 - ncbi.nlm.nih.gov
Ovarian cancer is one of the most lethal malignant gynecological tumors. More than 70% of
patients with ovarian cancer are diagnosed at advanced stage. The 5-year survival in …

MicroRNA signatures in human ovarian cancer

MV Iorio, R Visone, G Di Leva, V Donati, F Petrocca… - Cancer research, 2007 - AACR
Epithelial ovarian cancer (EOC) is the sixth most common cancer in women worldwide and,
despite advances in detection and therapies, it still represents the most lethal gynecologic …

The clinical and diagnostic role of microRNAs in ovarian carcinoma

B Davidson, CG Tropé, R Reich - Gynecologic oncology, 2014 - Elsevier
Abstract Objective MicroRNAs (miRNAs, miRs) are non-coding RNAs which post-
transcriptionally regulate mRNA synthesis. Data regarding the expression and clinical …

[HTML][HTML] MicroRNA and ovarian cancer

DC Corney, AY Nikitin - Histology and histopathology, 2008 - ncbi.nlm.nih.gov
Ovarian cancer remains a leading cause of morbidity and mortality, with little change in
survival rates over the past 30 years. Research in the molecular biology underlying the …

MicroRNAs in ovarian cancer biology and therapy resistance

MTM van Jaarsveld, J Helleman, EMJJ Berns… - The international journal …, 2010 - Elsevier
Epithelial ovarian cancer is the most common cause of death from gynecological
malignancies in the Western world. The overall 5-year survival is only 30% due to late …